Amazon pharmaceutical company PillPack has agreed to pay nearly $ 6 million after admitting to giving patients more insulin than allowed by Medicare and Medicaid, according to an agreement announced by the Justice Department. Monday.
Government health care programs such as Medicare and Medicaid limit the supply of medicines they will have at one time, limiting the amount of medicine a pharmacy can distribute to patients. In terms of dosage, PillPack will give patients a full box of insulin pills (consisting of 300 units of insulin), the amount above the limit. It will then falsify the insulin supplies given to patients for compensation claims submitted to health programs. Patients then received replenishment of their medications early.
“In some cases, over time, patients have accumulated large amounts of insulin that they do not need according to the medication,” the DOJ statement said. $ 5.79 million will be set up and given to the federal government and some state governments.
Amazon bought PillPack 2018 and used the company’s infrastructure to create its Amazon Pharmacy service. PillPack is still a separate service under the Amazon Pharmacy umbrella.
The lawsuit covered the period between April 2014 and November 2019. An Amazon spokesman was not named said Axios that the company has changed the practice of insulin distribution in 2019. Pharmacy benefit plans are allowed or required, ”the spokesman said.